Lactobacillus reuteri
Lactobacillus reuteri is a biological therapy with 27 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
4
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.9%
20 of 22 finished
9.1%
2 ended early
1
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis
Clinical Trials (27)
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis
Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis
Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic
Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women
Effects of Lactobacillus Reuteri in Premature Infants
Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea
Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru
Safety of Lactobacillus Reuteri in Healthy Volunteers
Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients
Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri
Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes
Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants
Lactobacillus Reuteri in Adult With Functional Chronic Constipation
Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic: a Prospective Study
Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 27